Clozapine REMS still plagued by problems

A consolidated registry system designed to increase access to the second-generation antipsychotic clozapine is plagued with glitches, delays, and excess red tape more than 8 months after its initial...

Source: Clinical Psychiatry News - May 11, 2016 Category: Psychiatry Source Type: research